What is Biomarkers for Biotech?
Almac Diagnostic Services ‘Biomarkers for Biotech’ is a package of solutions tailored to meet the specific needs of the biotech industry. We can help streamline your diagnostic activities, whilst helping you avoid potentially costly roadblocks along the way, ensuring the most cost-effective solution for your biomarker programme.
The Importance of Biomarkers
In today’s era of precision medicine, the discovery and validation of biomarkers and their development into clinical tests is critical. Biomarkers have wide ranging applications in drug development, from identifying the correct biological dose to selection of patients for therapy.
Maximise your drug’s potential
Almac Diagnostic Services can:
- Help you to Identify & navigate diagnostic pathway options in support of your drug development strategy
- Increase your drug’s value
- Improve your drug’s chances of success
Why Almac?
Almac offers a unique business model to biotech clients, providing complete flexibility to support the biomarker strategies required to deliver precision medicine, so that you are not tied to one solution and will always have the freedom to change.
Fee for service
qPCR, NGS, nanoString and others
Oncology and Chronic Diseases
Tissue, blood, saliva and a range of others
UK, Europe, USA and APAC
Our Consultancy Services
We offer a comprehensive consultancy service for biotech clients to help guide your precision medicine studies, whatever stage of the drug development journey you are at. These services can be offered as part of an overall product development package agreement or as a standalone consultancy agreement.
Almac Diagnostic Services regulatory affairs team has extensive experience in engaging with global regulatory authorities such as US (FDA), EU (MHRA), and China (NMPA) through our local Chinese agent. Almac can also give Biotech clients up to date guidance and support for your biomarker programmes around IVDR and compliance with the new regulations for Europe.
We offer a bespoke bioinformatics consultancy service which can guide your biomarker studies from study planning to final analysis and delivery of a validated biomarker. Our biostatistics team ensure that the right analyses will be chosen to facilitate appropriate characterisation of your assay. Our software development team help to identify key requirements at an early stage to tailor robust biomarker software solutions to meet your exact needs.